APA

Mengarelli A., Annibali O., Pimpinelli F., Riva E., Gumenyuk S., Renzi D., Cerchiara E., Piccioni L., Palombi F., Pisani F., Romano A., Spadea A., Papa E., Cordone I., Canfora M., Arcese W., Ensoli F. & Marchesi F. (20160526). Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. : The Journal of infection.

Chicago

Mengarelli A, Annibali O, Pimpinelli F, Riva E, Gumenyuk S, Renzi D, Cerchiara E, Piccioni L, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Cordone I, Canfora M, Arcese W, Ensoli F and Marchesi F. 20160526. Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. : The Journal of infection.

Harvard

Mengarelli A., Annibali O., Pimpinelli F., Riva E., Gumenyuk S., Renzi D., Cerchiara E., Piccioni L., Palombi F., Pisani F., Romano A., Spadea A., Papa E., Cordone I., Canfora M., Arcese W., Ensoli F. and Marchesi F. (20160526). Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. : The Journal of infection.

MLA

Mengarelli A, Annibali O, Pimpinelli F, Riva E, Gumenyuk S, Renzi D, Cerchiara E, Piccioni L, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Cordone I, Canfora M, Arcese W, Ensoli F and Marchesi F. Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. : The Journal of infection. 20160526.